Literature DB >> 28659707

Meige's syndrome.

Priyanka Gautam1, Manjeet Singh Bhatia1, Jaswinder Kaur1, Anubhav Rathi1.   

Abstract

Meige's syndrome consists of idiopathic blepharospasm and oromandibular dystonia. The exact etiology is not known and various hypotheses have been proposed for its causation. The hypothesis suggesting dopaminergic and cholinergic hyperactivity is most widely accepted. There is no curative drug for Meige's syndrome although a variety of treatments have been proposed. We report a case which responded to tetrabenazine.

Entities:  

Keywords:  Etiology; Meige's syndrome; oromandibular dystonia; tetrabenazine; treatment

Year:  2016        PMID： 28659707      PMCID： PMC5479101          DOI： 10.4103/0972-6748.207853

Source DB:  PubMed          Journal:  Ind Psychiatry J        ISSN： 0972-6748


  9 in total

Review 1.  Algorithms for neuroleptic-associated tardive movement disorders.

Authors:  K Akiyama
Journal:  Psychiatry Clin Neurosci       Date:  1999-10       Impact factor: 5.188

2.  Treatment of Meige's syndrome with ECT.

Authors:  R A Boshes; J A Afonso; K Tanev
Journal:  J ECT       Date:  1999-06       Impact factor: 3.635

Review 3.  Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Authors:  Jack J Chen; William G Ondo; Khashayar Dashtipour; David M Swope
Journal:  Clin Ther       Date:  2012-06-28       Impact factor: 3.393

4.  Meige's syndrome associated with neuroleptic treatment.

Authors:  J Ananth; E Edelmuth; B Dargan
Journal:  Am J Psychiatry       Date:  1988-04       Impact factor: 18.112

5.  Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.

Authors:  Craig N Czyz; John A Burns; Thomas P Petrie; John R Watkins; Kenneth V Cahill; Jill A Foster
Journal:  Am J Ophthalmol       Date:  2013-03-28       Impact factor: 5.258

6.  Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation.

Authors:  René Reese; Doreen Gruber; Thomas Schoenecker; Hansjörg Bäzner; Christian Blahak; H Holger Capelle; Daniela Falk; Jan Herzog; Marcus O Pinsker; Gerd H Schneider; Christoph Schrader; Günther Deuschl; Hubertus M Mehdorn; Andreas Kupsch; Jens Volkmann; Joachim K Krauss
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

7.  [Case of oromandibular dystonia presenting with severe impairment of mouth-opening, and a marked effect by administration of baclofen].

Authors:  Masamichi Ikawa; Makoto Yoneda; Hiroto Nakagawa; Masaru Kuriyama
Journal:  Rinsho Shinkeigaku       Date:  2006-09

8.  Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.

Authors:  N Poungvarin; V Devahastin; R Chaisevikul; N Prayoonwiwat; A Viriyavejakul
Journal:  J Med Assoc Thai       Date:  1997-01

9.  Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics.

Authors:  D Hípola; D Mateo; S Giménez-Roldán
Journal:  Eur Neurol       Date:  1984       Impact factor: 1.710
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.